Herein, we report an efficient two-step synthesis of novel benzo-fused sulfonimidate heterocycles, Benzo[e][1,2,3]oxathiazin-4-one-2-oxides. The first step involves the synthesis of sulfonimidate esters from tert-butyl N-sulfinyl carbamate and methyl salicylate via in situ formation of sulfonimidoyl chloride. These sulfonimidate esters undergo cyclization under acidic conditions at room temperature to afford Benzo[e][1,2,3]oxathiazin-4-one-2-oxide heterocycles. We also demonstrated the synthesis of both of the enantiomers of 2-(p-tolyl)benzo[e][1,2,3]oxathiazin-4-one-2-oxide from their respective enantiomerically pure sulfinyl carbamates. The reaction proceeds with inversion of configuration at the sulfur center, where (S)-tert-butyl N-(p-tolylsulfinyl) carbamate yields the corresponding R-isomer, and (R)-tert-butyl N-(p-tolylsulfinyl) carbamate affords the S-isomer. The structures of both racemic and chiral compounds were confirmed by X-ray crystallography. The practicality of the developed protocol was further demonstrated through gram-scale synthesis and mechanochemical methods. Furthermore, Benzoxathiazin-4-one-2-oxides proved to be amenable to the late-stage functionalization, expanding their synthetic utility.
No takes yet. Share an insight, caveat, or question.
Patil et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: